Showing results (881-890 of 2,915) with videos related to
Sort By:
Pageof 292
Cancer Gene Therapy|April 29, 2020
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trialsKhalil Choucair, Susan Morand, Laura Stanbery, et al.Cancer Gene Therapy|September 15, 2021
Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt/β-catenin signaling pathway by downregulating USP6Shuai Wu, Mei Han, Chao ZhangCancer Gene Therapy|May 2, 2020
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40Jessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström, et al.Cancer Gene Therapy|May 7, 2020
UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53Yexiang Huang, Yuyan Zhu, Zhe Zhang, et al.Cancer Gene Therapy|November 20, 2004
Short interfering RNAs as a tool for cancer gene therapyMarta IzquierdoCancer Gene Therapy|December 18, 2004
Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virusHuijie Bian, Philippe Fournier, Rob Moormann, et al.Cancer Gene Therapy|April 29, 2006
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitroL Vujanovic, E Ranieri, A Gambotto, et al.Cancer Gene Therapy|July 11, 2006
Phase I clinical trial of a TGF-beta antisense-modified tumor cell vaccine in patients with advanced gliomaH Fakhrai, J C Mantil, L Liu, et al.Cancer Gene Therapy|March 19, 2005
Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cellsShaoyi Li, Tsutomu Tokuyama, Junkoh Yamamoto, et al.Cancer Gene Therapy|February 12, 2005
Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cellsQiang-Song Tong, Li-Duan Zheng, Liang Wang, et al.Pageof 292